Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellu (Q43456447)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2001

Language	Label	Description	Also known as
English	Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellu	scientific article published in December 2001

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Enhanced CD8+ T cell immune response against a V3 loop multi-epitope polypeptide (TAB13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellu (English)

1 reference

Europe PubMed Central

23 November 2017

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

Carmen E Gómez

1

1 reference

Europe PubMed Central

23 November 2017

Mariano Esteban

6

object named as

Esteban M

1 reference

Europe PubMed Central

23 November 2017

author name string

Rodríguez D

2

1 reference

Europe PubMed Central

23 November 2017

Rodríguez JR

3

1 reference

Europe PubMed Central

23 November 2017

Abaitua F

4

1 reference

Europe PubMed Central

23 November 2017

Duarte C

5

1 reference

Europe PubMed Central

23 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

20

1 reference

Europe PubMed Central

23 November 2017

5-6

1 reference

Europe PubMed Central

23 November 2017

961-971

1 reference

Europe PubMed Central

23 November 2017

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses in HIV-exposed seronegatives: have they repelled the virus?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of human immunodeficiency virus type 1 (HIV-1)-specific cytolytic T lymphocyte responses in seronegative adults by a nonreplicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A V3 loop haptenic peptide sequence, when tandemly repeated, enhances immunogenicity by facilitating helper T-cell responses to a covalently linked carrier protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Envelope protein and p18(IIIB) peptide recognized by cytotoxic T lymphocytes from humans immunized with human immunodeficiency virus envelope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18IIIB peptide in an HLA-A11-immunized individual

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Broadly reactive antibodies against a gp120 V3 loop multi-epitope polypeptide neutralize different isolates of human immunodeficiency virus type 1 (HIV-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The V3 loop based multi-epitope polypeptide TAB9 adjuvated with montanide ISA720 is highly immunogenic in nonhuman primates and induces neutralizing antibodies against five HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccinia virus: a tool for research and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Applications of pox virus vectors to vaccination: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony-stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mucosal and systemic immune responses induced after oral delivery of vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of CD8+ T cells using heterologous prime-boost immunisation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and characterization of attenuated mutants of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of antigen specific CD8+ T cells using an ELISPOT assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on poxvirus infections in irradiated animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral mechanisms of immune evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Humoral immune response elicited by highly attenuated variants of vaccinia virus and by an attenuated recombinant expressing HIV-1 envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900389-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(01)00389-9

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43456447&oldid=2115368497"